| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.041 | 0.4 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.057 | 0.4 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.4 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | 0.14 | 0.4 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.13 | 0.4 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.4 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |